Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

300 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Stress-induced hyperviscosity in the pathophysiology of takotsubo cardiomyopathy.
Cecchi E, Parodi G, Giglioli C, Passantino S, Bandinelli B, Liotta AA, Bellandi B, Cioni G, Costanzo M, Abbate R, Gensini GF, Antoniucci D, Mannini L. Cecchi E, et al. Among authors: antoniucci d. Am J Cardiol. 2013 May 15;111(10):1523-9. doi: 10.1016/j.amjcard.2013.01.304. Am J Cardiol. 2013. PMID: 23465096
Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients.
Giusti B, Gori AM, Marcucci R, Saracini C, Sestini I, Paniccia R, Valente S, Antoniucci D, Abbate R, Gensini GF. Giusti B, et al. Among authors: antoniucci d. Pharmacogenet Genomics. 2007 Dec;17(12):1057-64. doi: 10.1097/FPC.0b013e3282f1b2be. Pharmacogenet Genomics. 2007. PMID: 18004210
First-in-human evaluation of a novel sirolimus-eluting ultra-high molecular weight APTITUDE bioresorbable scaffold: 9- and 24-month imaging and clinical results of the RENASCENT II trial.
Chieffo A, Khawaja SA, Latib A, Vesga B, Moncada M, Delgado JA, Fonseca J, Testa L, Esposito G, Ferrone M, Cortese B, Maehara A, Granada JF, Colombo A; Collaborators. Chieffo A, et al. EuroIntervention. 2020 Jun 12;16(2):e133-e140. doi: 10.4244/EIJ-D-19-00600. EuroIntervention. 2020. PMID: 32149709 Free article. Clinical Trial.
Five-year clinical outcome of multicenter randomized trial comparing amphilimus - with paclitaxel-eluting stents in de novo native coronary artery lesions.
Carrié D, Berland J, Verheye S, Hauptmann KE, Vrolix M, Musto C, Berti S, Dibié A, Maupas E, Antoniucci D, Schofer J. Carrié D, et al. Among authors: antoniucci d. Int J Cardiol. 2020 Feb 15;301:50-55. doi: 10.1016/j.ijcard.2019.10.058. Epub 2019 Nov 15. Int J Cardiol. 2020. PMID: 31759686 Clinical Trial.
Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
Schüpke S, Neumann FJ, Menichelli M, Mayer K, Bernlochner I, Wöhrle J, Richardt G, Liebetrau C, Witzenbichler B, Antoniucci D, Akin I, Bott-Flügel L, Fischer M, Landmesser U, Katus HA, Sibbing D, Seyfarth M, Janisch M, Boncompagni D, Hilz R, Rottbauer W, Okrojek R, Möllmann H, Hochholzer W, Migliorini A, Cassese S, Mollo P, Xhepa E, Kufner S, Strehle A, Leggewie S, Allali A, Ndrepepa G, Schühlen H, Angiolillo DJ, Hamm CW, Hapfelmeier A, Tölg R, Trenk D, Schunkert H, Laugwitz KL, Kastrati A; ISAR-REACT 5 Trial Investigators. Schüpke S, et al. Among authors: antoniucci d. N Engl J Med. 2019 Oct 17;381(16):1524-1534. doi: 10.1056/NEJMoa1908973. Epub 2019 Sep 1. N Engl J Med. 2019. PMID: 31475799 Clinical Trial.
One-Year Follow-Up Results From the Observational, Multicenter, Prospective, and Controlled Registry: The WALTZ All-Comers Study.
Rodriguez AE, Larribau M, Fernandez-Pereira C, Iravedra J, Santaera O, Haiek C, Lloberas J, Montoya M, Sisu E, Menendez M, Pavlovsky H, Rodriguez-Granillo AM, Mieres J, Romero G, Ming Z, Pan W, Antoniucci D. Rodriguez AE, et al. Among authors: antoniucci d. Clin Med Insights Cardiol. 2019 Jun 27;13:1179546819854059. doi: 10.1177/1179546819854059. eCollection 2019. Clin Med Insights Cardiol. 2019. PMID: 31285655 Free PMC article.
300 results